2011
DOI: 10.1186/1752-153x-5-48
|View full text |Cite
|
Sign up to set email alerts
|

Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles

Abstract: Many studies are currently investigating the development of safe and effective vaccines to prevent various infectious diseases. Multiple antigen-presenting peptide vaccine systems have been developed to avoid the adverse effects associated with conventional vaccines (i.e., live-attenuated, killed or inactivated pathogens), carrier proteins and cytotoxic adjuvants. Recently, two main approaches have been used to develop multiple antigen-presenting peptide vaccine systems: (1) the addition of functional componen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
42
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 69 publications
(42 citation statements)
references
References 120 publications
0
42
0
Order By: Relevance
“…They are also expected to surpass vaccines produced with attenuated or genetically-modified bacteria [12][13]. Synthetic immunogenic peptides are desirable components for subunit vaccines because unlike traditional vaccines they a) carry no infectious material, b) have no cross-reactivity with host tissues, c) can induce site-specific antibodies, d) are chemically defined and can be modified, and e) allow for swift large-scale manufacturing and long-term storage in the event of a pandemic [34].…”
Section: Discussionmentioning
confidence: 99%
“…They are also expected to surpass vaccines produced with attenuated or genetically-modified bacteria [12][13]. Synthetic immunogenic peptides are desirable components for subunit vaccines because unlike traditional vaccines they a) carry no infectious material, b) have no cross-reactivity with host tissues, c) can induce site-specific antibodies, d) are chemically defined and can be modified, and e) allow for swift large-scale manufacturing and long-term storage in the event of a pandemic [34].…”
Section: Discussionmentioning
confidence: 99%
“…The current field is still developing but there are reports on the use of gold nanoparticles in vaccine delivery in some diseases due to their small size and ability to enter the cell easily. Fujita and Taguchi (2011) proposed that gold nanoparticle-based vaccines can be developed by two ways; the first one includes addition of functional components (T cell epitopes, cell-penetrating peptides and lipophilic moieties) and the second one is known as the synthetic approach, which is achieved by using size-defined nanomaterials (self-assembling peptides, non-peptidic dendrimers and gold nanoparticles) as antigen-displaying platforms.…”
Section: Gold Nanoparticlesmentioning
confidence: 99%
“…Multiple antigenic peptide (MAP) dendrimer system is being used for vaccine and immunization purposes. MAP-based delivery can prepare by addition of multiple immune-functional components, like B/T-cell epitopes, cell-penetrating peptides, and lipophilic moieties or by controlled synthesis of nanomaterials like micelles, dendrimers, and nanoparticles (Fujita and Taguchi 2011). A tetravalent multiple antigen peptide (MAP) dendrimer with four identical branches of a C-terminal peptide sequence of the rat GH-BP (GH-BP263-279) was synthesized and used as an immunogen in rabbits.…”
Section: Dendrimermentioning
confidence: 99%